Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year earnings per share growth rate
Latest
99.76%
↑ 904% above average
Average (9y)
-12.41%
Historical baseline
Range
High:210.77%
Low:-216.67%
CAGR
+22.3%
Consistent expansion
| Period | Value |
|---|---|
| 2025 | 99.76% |
| 2024 | -161.78% |
| 2023 | -14.37% |
| 2022 | -22.79% |
| 2021 | -61.90% |
| 2020 | -216.67% |
| 2019 | 210.77% |
| 2018 | -38.30% |
| 2017 | 64.93% |
| 2016 | 16.25% |